Stock listing
KRX:331920 Celemics, Inc. (셀레믹스) 주가
Follow Celemics, Inc. into a list and get an email when it puts out news.
Share price · KRX:331920
₩5,920.00 KRW -940.00 (-13.7%)
Close on Nov 20, 2026
- Day range
- ₩5,520.00 – ₩6,450.00 KRWNov 20, 2026
- Volume
- 39,927 sharesNov 20, 2026
- Market cap
- ₩66.19B KRWAt the close on Nov 20, 2026 · price × 11.18M shares outstanding
- 52-week range
- ₩2,535.00 – ₩19,840.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩790.4M KRWMedian day 46,011 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:331920 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩5,920.00 | -940.00 | -13.7% | ₩6,200.00 | ₩6,450.00 | ₩5,520.00 | 39,927 | |
| ₩6,860.00 | -50.00 | -0.7% | ₩6,150.00 | ₩6,860.00 | ₩5,020.00 | 354,951 | |
| ₩6,910.00 | +210.00 | +3.1% | ₩6,700.00 | ₩7,140.00 | ₩6,630.00 | 33,525 | |
| ₩6,700.00 | -720.00 | -9.7% | ₩7,420.00 | ₩7,420.00 | ₩6,530.00 | 106,496 | |
| ₩7,420.00 | -260.00 | -3.4% | ₩7,680.00 | ₩7,810.00 | ₩6,950.00 | 94,446 | |
| ₩7,680.00 | -310.00 | -3.9% | ₩8,030.00 | ₩8,030.00 | ₩7,500.00 | 42,191 | |
| ₩7,990.00 | 0.00 | 0.0% | ₩7,970.00 | ₩8,060.00 | ₩7,770.00 | 40,952 | |
| ₩7,990.00 | +200.00 | +2.6% | ₩8,250.00 | ₩8,250.00 | ₩7,450.00 | 50,477 | |
| ₩7,790.00 | -380.00 | -4.7% | ₩8,150.00 | ₩8,150.00 | ₩7,380.00 | 52,078 | |
| ₩8,170.00 | -70.00 | -0.8% | ₩7,830.00 | ₩8,240.00 | ₩7,400.00 | 32,967 | |
| ₩8,240.00 | -490.00 | -5.6% | ₩8,870.00 | ₩9,180.00 | ₩8,080.00 | 45,596 | |
| ₩8,730.00 | +490.00 | +5.9% | ₩7,920.00 | ₩8,890.00 | ₩7,900.00 | 73,203 | |
| ₩8,240.00 | -600.00 | -6.8% | ₩8,980.00 | ₩8,980.00 | ₩8,180.00 | 33,961 | |
| ₩8,840.00 | -390.00 | -4.2% | ₩8,780.00 | ₩9,210.00 | ₩8,140.00 | 73,507 | |
| ₩9,230.00 | +10.00 | +0.1% | ₩9,260.00 | ₩9,270.00 | ₩8,280.00 | 91,460 | |
| ₩9,220.00 | -10.00 | -0.1% | ₩9,200.00 | ₩9,300.00 | ₩8,850.00 | 15,467 | |
| ₩9,230.00 | +10.00 | +0.1% | ₩9,220.00 | ₩9,500.00 | ₩9,040.00 | 9,859 | |
| ₩9,220.00 | +610.00 | +7.1% | ₩8,900.00 | ₩9,220.00 | ₩8,340.00 | 60,979 | |
| ₩8,610.00 | -1,060.00 | -11.0% | ₩9,500.00 | ₩9,500.00 | ₩8,450.00 | 137,747 | |
| ₩9,670.00 | -310.00 | -3.1% | ₩10,260.00 | ₩10,260.00 | ₩9,460.00 | 77,471 | |
| ₩9,980.00 | -90.00 | -0.9% | ₩10,170.00 | ₩10,400.00 | ₩9,710.00 | 54,456 | |
| ₩10,070.00 | +260.00 | +2.7% | ₩10,120.00 | ₩10,120.00 | ₩9,550.00 | 30,891 | |
| ₩9,810.00 | -380.00 | -3.7% | ₩10,380.00 | ₩10,380.00 | ₩9,730.00 | 26,796 | |
| ₩10,190.00 | -20.00 | -0.2% | ₩10,210.00 | ₩10,470.00 | ₩9,990.00 | 15,944 | |
| ₩10,210.00 | +370.00 | +3.8% | ₩9,740.00 | ₩10,710.00 | ₩9,740.00 | 45,555 | |
| ₩9,840.00 | +200.00 | +2.1% | ₩9,520.00 | ₩10,000.00 | ₩9,060.00 | 37,106 | |
| ₩9,640.00 | -370.00 | -3.7% | ₩9,990.00 | ₩10,500.00 | ₩9,640.00 | 17,527 | |
| ₩10,010.00 | -70.00 | -0.7% | ₩10,080.00 | ₩10,370.00 | ₩9,470.00 | 38,102 | |
| ₩10,080.00 | -750.00 | -6.9% | ₩10,780.00 | ₩10,780.00 | ₩9,950.00 | 53,806 | |
| ₩10,830.00 | +400.00 | +3.8% | ₩10,200.00 | ₩10,860.00 | ₩9,870.00 | 79,666 | |
| ₩10,430.00 | +320.00 | +3.2% | ₩10,110.00 | ₩11,000.00 | ₩9,970.00 | 173,640 | |
| ₩10,110.00 | -560.00 | -5.2% | ₩10,580.00 | ₩10,650.00 | ₩9,980.00 | 71,931 | |
| ₩10,670.00 | +430.00 | +4.2% | ₩10,080.00 | ₩10,690.00 | ₩9,930.00 | 41,376 | |
| ₩10,240.00 | -40.00 | -0.4% | ₩10,270.00 | ₩10,460.00 | ₩9,930.00 | 41,964 | |
| ₩10,280.00 | -390.00 | -3.7% | ₩10,510.00 | ₩10,510.00 | ₩10,000.00 | 21,616 | |
| ₩10,670.00 | +60.00 | +0.6% | ₩10,450.00 | ₩11,000.00 | ₩9,870.00 | 70,826 | |
| ₩10,610.00 | -740.00 | -6.5% | ₩11,450.00 | ₩11,450.00 | ₩10,310.00 | 40,408 | |
| ₩11,350.00 | +420.00 | +3.8% | ₩11,010.00 | ₩13,120.00 | ₩10,870.00 | 92,326 | |
| ₩10,930.00 | +70.00 | +0.6% | ₩11,150.00 | ₩11,150.00 | ₩10,740.00 | 14,314 | |
| ₩10,860.00 | -440.00 | -3.9% | ₩11,460.00 | ₩11,460.00 | ₩10,760.00 | 33,814 | |
| ₩11,300.00 | +70.00 | +0.6% | ₩11,310.00 | ₩11,690.00 | ₩10,520.00 | 59,021 | |
| ₩11,230.00 | -190.00 | -1.7% | ₩11,410.00 | ₩11,440.00 | ₩10,140.00 | 151,035 | |
| ₩11,420.00 | -650.00 | -5.4% | ₩12,270.00 | ₩12,270.00 | ₩11,240.00 | 51,092 | |
| ₩12,070.00 | -720.00 | -5.6% | ₩13,050.00 | ₩13,050.00 | ₩11,350.00 | 95,058 | |
| ₩12,790.00 | -1,010.00 | -7.3% | ₩13,680.00 | ₩13,680.00 | ₩12,110.00 | 60,299 | |
| ₩13,800.00 | -260.00 | -1.8% | ₩13,800.00 | ₩14,100.00 | ₩12,660.00 | 29,221 | |
| ₩14,060.00 | +10.00 | +0.1% | ₩14,090.00 | ₩14,190.00 | ₩13,930.00 | 15,778 | |
| ₩14,050.00 | +60.00 | +0.4% | ₩13,990.00 | ₩14,150.00 | ₩13,830.00 | 23,743 | |
| ₩13,990.00 | -270.00 | -1.9% | ₩14,680.00 | ₩14,680.00 | ₩13,980.00 | 12,048 | |
| ₩14,260.00 | -210.00 | -1.5% | ₩14,980.00 | ₩14,980.00 | ₩14,260.00 | 16,255 | |
| ₩14,470.00 | +170.00 | +1.2% | ₩14,290.00 | ₩14,890.00 | ₩14,000.00 | 35,777 | |
| ₩14,300.00 | -50.00 | -0.3% | ₩14,650.00 | ₩14,980.00 | ₩14,280.00 | 46,425 | |
| ₩14,350.00 | -10.00 | -0.1% | ₩14,360.00 | ₩14,510.00 | ₩13,250.00 | 67,525 | |
| ₩14,360.00 | +1,290.00 | +9.9% | ₩13,080.00 | ₩15,000.00 | ₩12,870.00 | 129,951 | |
| ₩13,070.00 | +120.00 | +0.9% | ₩12,950.00 | ₩13,380.00 | ₩11,820.00 | 63,572 | |
| ₩12,950.00 | +2,060.00 | +18.9% | ₩10,950.00 | ₩13,650.00 | ₩10,400.00 | 599,871 | |
| ₩10,890.00 | +2,510.00 | +30.0% | ₩8,590.00 | ₩10,890.00 | ₩8,420.00 | 590,666 | |
| ₩8,380.00 | -290.00 | -3.3% | ₩8,770.00 | ₩9,090.00 | ₩8,350.00 | 29,302 | |
| ₩8,670.00 | -230.00 | -2.6% | ₩8,880.00 | ₩8,880.00 | ₩8,270.00 | 47,788 | |
| ₩8,900.00 | +300.00 | +3.5% | ₩8,690.00 | ₩9,060.00 | ₩8,460.00 | 40,395 | |
| ₩8,600.00 | -440.00 | -4.9% | ₩9,050.00 | ₩9,050.00 | ₩8,240.00 | 60,321 | |
| ₩9,040.00 | +50.00 | +0.6% | ₩9,210.00 | ₩9,380.00 | ₩8,900.00 | 19,041 |
- Ticker
- KRX:331920
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news release · Sep 1, 2026
Celemics Signs License Out Agreement With Achieve Diagnostics With Minimum $2.5 Million Royalty Payment
Latest news
Celemics Signs License Out Agreement With Achieve Diagnostics With Minimum $2.5 Million Royalty Payment
Sep 1, 2026
Closed ₩14,360 (+9.9%) on Sep 1, 2026
Celemics, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 1 in the last 12 months · 1 in all · newest Sep 1, 2026 · oldest 2026
Valuation
EV/sales 8.4× against a median of 0.9×: 9th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩43.67B KRW
- P/E
- Loss
- EV/sales
- 8.4×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.2×
- Gross margin
- 42.8%
- Operating margin
- −74.4%
- Net margin
- −260.9%
- Debt to equity
- 0.5×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Celemics, Inc. · KRX:331920 | US$49.19M | US$32.45M | n/a | 8.4× | n/a | 2.2× | −260.9% | 0.5× | n/a |
| Champions Oncology, Inc. · NASDAQ:CSBR | US$60.41M | US$56.05M | n/a | 0.9× | 168× | 15.5× | −1.9% | 0.0× | 0.40 |
| DreamCIS, Inc. · KRX:223250 | US$60.14M | US$33.22M | 246× | 0.6× | 5.4× | 1.1× | 0.4% | 0.0× | n/a |
| Lumos Diagnostics Holdings Ltd. · ASX:LDX | US$47.13M | US$37.65M | n/a | 2.8× | n/a | 2.1× | −37.5% | 0.3× | n/a |
| Renalytix PLC · LSE:RENX | US$45.63M | US$45.23M | n/a | 15.1× | n/a | n/a | −680.0% | n/a | n/a |
| Labiana Health SA · BME:LAB | US$44.32M | US$70.53M | 15.7× | 0.9× | 5.8× | 8.0× | 3.4% | 5.9× | n/a |
| Access Bio, Inc. · KRX:950130 | US$44.14M | −US$191.0M | n/a | −10.8× | n/a | 0.1× | −468.1% | 0.0× | n/a |
| EDX Medical Group plc · LSE:EDX | US$43.76M | US$39.94M | n/a | 92.3× | n/a | 15.4× | n/a | 0.0× | n/a |
| Osang Healthcare Co. Ltd. · KRX:036220 | US$42.34M | US$24.18M | n/a | 0.3× | n/a | 0.2× | −8.8% | 0.1× | n/a |
| ABL Diagnostics SA · EURONEXT:ABLD | US$41.24M | US$42.29M | 38.1× | 5.5× | 42.8× | 5.3× | 14.2% | 0.3× | n/a |
| hVIVO plc · LSE:HVO | US$41.00M | US$42.22M | n/a | 0.7× | 7.5× | 1.0× | −12.8% | 0.4× | n/a |
| Median of the others | US$44.23M | US$41.08M | 38.1× | 0.9× | 7.5× | 2.1× | −8.8% | 0.1× | 0.40 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | May 13, 2026 · Before open | −3.1% |
| Q4 2025 | Mar 17, 2026 · Before open | +5.9% |
| Q3 2025 | Nov 12, 2025 · Before open | +0.5% |
| Q2 2025 | Aug 12, 2025 · Before open | +1.9% |
| Q1 2025 | May 15, 2025 · Before open | −1.5% |
| Q4 2024 | Mar 19, 2025 · After close | −0.7% |
| Q3 2024 | Nov 12, 2024 · After close | −2.4% |
| Q2 2024 | Aug 14, 2024 · After close | −7.6% |
| Q1 2024 | May 17, 2024 · After close | −1.6% |
| Q4 2023 | Mar 21, 2024 · After close | +0.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2023 | Nov 14, 2023 · After close | +2.4% |
| Q2 2023 | Aug 16, 2023 · After close | −1.2% |
| Q1 2023 | May 15, 2023 · After close | 0.0% |
| Q4 2022 | Mar 21, 2023 · After close | +0.3% |
| Q3 2022 | Nov 14, 2022 | +2.7% |
| Q2 2022 | Aug 16, 2022 · Before open | −0.3% |
| Q1 2022 | May 13, 2022 · Before open | +1.4% |
| Q3 2021 | Nov 15, 2021 · After close | +0.3% |
| Quarter to Jun 30, 2021 | Aug 17, 2021 · After close | −0.6% |
| Quarter to Mar 31, 2021 | May 17, 2021 | −3.6% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.77B | 6.72B | 6.58B | 8.73B | 8.08B | 5.27B | 5.14B | 2.52B | 2.06B | |
| Cost of revenue | 2.90B | 3.04B | 5.06B | 6.31B | 5.25B | 4.18B | 4.38B | 2.31B | 1.79B | |
| Gross profit | 2.87B | 3.68B | 1.52B | 2.42B | 2.83B | 1.09B | 758.3M | 213.2M | 277.1M | |
| Research and development | 1.04B | 966.0M | 1.31B | 2.21B | 2.66B | 1.49B | ||||
| Selling, general and administrative | 1.90B | 4.33B | 5.66B | 5.57B | 5.77B | 4.14B | 3.74B | 2.65B | 3.82B | |
| Operating income | -3.32B | -1.90B | -5.77B | -5.73B | -6.02B | -4.89B | -5.06B | -4.12B | -3.54B | |
| Depreciation and amortization | 720.0M | 752.6M | 810.5M | 843.6M | 777.7M | 674.4M | 666.6M | 341.3M | 295.2M | 284.1M |
| EBITDA | -2.60B | -1.15B | -4.96B | -4.89B | -5.24B | -4.22B | -4.39B | -3.78B | -3.24B | |
| Interest expense | 15.2M | 26.6M | 39.8M | 53.9M | 34.7M | 33.9M | 0 | 0 | 0 | 0 |
| Income before tax | -4.04B | 12.3B | -3.88B | -4.80B | -5.24B | -4.71B | -2.26B | -19.5B | -1.72B | |
| Net income | -4.04B | 12.3B | -3.88B | -4.80B | -5.24B | -4.71B | -2.26B | -19.5B | -1.72B | |
| Earnings per share, basic | -494.41 | 1,502.48 | -474.72 | -587.56 | -641.57 | -581.40 | -350.01 | -3,033.38 | -267.12 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.21B | 3.96B | 2.58B | 2.25B | 5.98B | 2.63B | 696.1M | 1.52B | 1.29B | |
| Short-term investments | 2.70B | 6.09B | 8.11B | 10.7B | 15.1B | 23.4B | 1.40B | 3.00B | 105.4M | |
| Receivables | 750.2M | 543.3M | 580.0M | 906.3M | 1.04B | 1.29B | 1.81B | 1.44B | 605.3M | 429.8M |
| Inventory | 1.47B | 1.10B | 942.6M | 1.39B | 679.5M | 773.8M | 444.4M | 551.0M | 336.2M | 289.2M |
| Current assets | 8.44B | 12.1B | 12.7B | 15.6B | 23.0B | 28.3B | 4.51B | 6.61B | 2.38B | 2.05B |
| Property, plant and equipment | 1.80B | 2.44B | 3.06B | 3.35B | 1.72B | 2.19B | 1.61B | 1.93B | 1.67B | |
| Total assets | 24.4B | 29.4B | 18.1B | 22.2B | 26.9B | 30.6B | 7.20B | 8.77B | 5.49B | |
| Accounts payable | 91.9M | 141.9M | 113.3M | 533.4M | 366.7M | 382.2M | 345.6M | |||
| Current liabilities | 1.28B | 1.97B | 1.65B | 2.64B | 2.02B | 1.14B | 1.45B | 24.0B | 1.10B | 1.02B |
| Long-term debt | 0 | 31.5M | 30.4M | 29.3M | 0 | 14.9B | 8.60B | |||
| Total debt | 20.0M | 925.5M | 15.3B | 9.00B | ||||||
| Total liabilities | 1.39B | 2.23B | 2.24B | 3.62B | 3.51B | 1.24B | 2.04B | 39.0B | 16.2B | |
| Shareholders' equity | 23.0B | 27.2B | 15.9B | 18.6B | 23.4B | 29.4B | 5.16B | -30.2B | -10.7B | |
| Shares outstanding | 8.16M | 8.16M | 8.16M | 8.16M | 8.16M | 8.11M | 6.44M | 6.44M | 6.44M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3.60B | -380.2M | -4.53B | -4.15B | -3.20B | -4.55B | -5.37B | -5.34B | -3.72B | -3.78B |
| Capital spending | -165.8M | -116.7M | -219.3M | -550.9M | -574.2M | -421.9M | -138.1M | -42.9M | -703.9M | -369.8M |
| Free cash flow | -3.76B | -496.9M | -4.75B | -4.70B | -3.77B | -4.97B | -5.51B | -5.38B | -4.43B | -4.15B |
| Cash from investing | 2.04B | 5.28B | 893.7M | 1.44B | -21.7B | 2.31B | -2.13B | -1.04B | -508.7M | |
| Cash from financing | -367.6M | -406.5M | -475.7M | -109.0M | 28.1B | 2.18B | 8.01B | 4.90B | 5.28B | |
| Share buybacks | 23.6K | 346.4M | 28.8B | 2.00B | ||||||
| Change in cash | -747.8M | 1.38B | 333.1M | -3.73B | -1.87B | 1.75B | -873.0M | 538.9M | 131.9M | 992.9M |
Cap table
Built by 6ix from Celemics, Inc.’s releases
- Common shares
- 11,181,555
- Fully diluted
- 11,181,555
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 11,181,555 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 11,181,555 |
Log in to ask 6ix AI your own questions about Celemics, Inc.